Studies have shown that both loganin (20–40 mg/kg) and geniposide (100–200 mg/kg) could inhibit URAT1 activity and promote uric acid excretion in potassium oxonate-induced hyperuricemia mice [63, 65]. The gene discussed is SLC22A12; the disease is hyperuricemia.